AEMD — AETHLON MEDICAL INC
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 882291 ·
Last close
$2.64
Market Cap
$1.88M
52W High
$3.75
52W Low
$0.53
ADV30
64,540
Next earnings
2026-11-11
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -1,929,296 | -1,884,266 | 6,333,107 | 5,026,458 | 1,446,835 |
| Dec 2025 | 0 | — | -2,062,116 | -2,018,245 | 8,057,128 | 6,956,397 | 1,344,031 |
| Sep 2025 | 0 | — | -1,509,830 | -1,487,100 | 7,323,090 | 5,853,493 | 1,577,113 |
| Jun 2025 | 0 | — | -1,792,390 | -1,761,858 | 5,306,002 | 3,765,154 | 1,882,489 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-6,998,392
Investing CF
$-2,051
Financing CF
$6,521,904
CapEx
$-2,051
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-292.00
As of
2026-08-16
Balance + Analyst (yfinance extras)
Retained Earnings
$-175,106,286
Inventory
—
Receivables
$218,314
ST Investments
—
EBIT TTM
$-7,137,098
Pretax Income TTM
$-7,151,469
Interest Exp TTM
—
Analysts
2
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | -7,293,631 | -7,151,469 | 6,333,107 | 1,446,835 | — | -6,998,392 |
| Mar 2025 | 0 | -9,341,365 | -13,388,089 | 7,359,534 | 2,236,004 | — | -7,645,532 |
| Mar 2024 | 0 | -12,636,568 | -12,208,174 | 8,245,982 | 2,479,650 | — | -10,129,810 |
| Mar 2023 | 574,245 | -11,898,638 | -12,029,786 | 17,508,940 | 2,444,730 | — | -10,505,128 |
| Mar 2022 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.57
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ALUR | ALLURION TECHNOLOGIES, INC. | $2.01M | $2.01 | — |
| YBGJ | Yubo International Biotech Ltd | $2.03M | $0.01 | — |
| NUMD | Nu-Med Plus, Inc. | $2.03M | $0.02 | — |
| BBLG | Bone Biologics Corp | $1.67M | $0.61 | — |
| VYCO | VYCOR MEDICAL INC | $2.27M | $0.07 | — |
News headlines (Yahoo Finance, 1h cache)
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program
2026-08-13 20:15 · Yahoo
Aethlon Medical Continues to Observe Directional Changes in Second Cohort of Australian Oncology Clinical Trial Evaluating Hemopurifier®
2026-07-13 12:01 · Yahoo
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules
2026-07-06 13:25 · Yahoo
Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®
2026-06-26 12:01 · Yahoo
Aethlon Medical advances Hemopurifier study as final trial cohort nears completion
2026-06-17 16:18 · Yahoo
Aethlon Medical Inc (AEMD) Q4 2026 Earnings Call Highlights: Strategic Advances Amid Financial ...
2026-06-17 01:00 · Yahoo
Aethlon (AEMD) Q4 2026 Earnings Transcript
2026-06-10 22:15 · Yahoo
Aethlon Medical Announces Fiscal Year End March 31, 2026 Financial Results and Corporate Update
2026-06-10 20:15 · Yahoo
Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026
2026-06-02 12:01 · Yahoo
Aethlon Medical Monitoring Current Ebola Outbreak and Reaffirms Outbreak/Pandemic Preparedness
2026-05-21 12:01 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.